Synopsis: Domenii: Health: Health generale: Illness:


www.nanotech-now.com 2015 000070.txt

2015sensors The Universitat Politcnica de Valncia is coordinating a European project to develop a device for the quick and early diagnosis of cancer March 7th,

2015military The Universitat Politcnica de Valncia is coordinating a European project to develop a device for the quick and early diagnosis of cancer March 7th,


www.nanotech-now.com 2015 000075.txt

March 10th, 2015photonics/Optics/Lasers Innovative light therapy reaches deep tumors March 9th, 2015quantum sensor's advantages survive entanglement breakdown:

2015the Universitat Politcnica de Valncia is coordinating a European project to develop a device for the quick and early diagnosis of cancer March 7th,


www.nanotech-now.com 2015 000093.txt

This could be especially beneficial to immunosuppressed individuals such as cancer patients. Administering a vaccine to protect against infection would overwhelm the patient's immune system.

However, if he or she has the option of receiving an antiviral to eliminate the infection,

the norovirus becomes much less dangerous


www.nanotech-now.com 2015 00556.txt.txt

#Microchip captures clusters of circulating tumor cells--NIH study Circulating tumor cells (CTCS) are cells that break away from a tumor and move through a cancer patient's bloodstream.

Single CTCS are extremely rare, typically fewer than 1 in 1 billion cells. These cells can take up residence in distant organs,

and researchers believe this is one mode by which cancer spreads. Even less common than single CTCS are small groups of CTCS, or clusters.

"Very little is known about CTC clusters and their role in the progression and metastasis of cancer.

M d."This is the kind of breakthrough technology that could have a very large impact on cancer research."

which funds transformative technological innovation designed to solve major medical problems with a substantial disease burden,

such as preventing cancer metastasis or precisely tailoring therapeutics to an individual's cancer cell biology. Toner and his collaborator Dr. Daniel Haber, M d.,Ph d.,also at MGH, recently used Cluster-Chip to capture

and melanoma cancers. The researchers found CTC clusters--ranging from two to 19 cells--in 30-40 percent of the patients."

and occasionally clusters using antibodies that stick to special proteins found on the surface of some tumor cells.

This latter property makes the Cluster-Chip well-suited for capturing CTC clusters from a range of cancer types,

including those that lose surface proteins during metastasis and those that never express them, such as melanoma.

The researchers went on to test the Cluster-Chip in a small trial of 60 patients with metastatic cancer.

In this study, the chip captured CTC clusters in 11 of 27 (40.7 percent) breast cancer patients, 6 of 20 (30 percent) melanoma patients

and an association between the presence of clusters and reduced survival in prostate cancer patients.

the researchers measured a marker of tumor cell proliferation--an indicator of increased invasiveness and poor outcomes--in one breast cancer patient with high numbers of both single CTCS and clusters.

The researchers also noted the rare presence of non-tumor cells within clusters in less than 5 percent of patients."

"Given the increasing number of cancer therapies that engage the immune system, the ability to monitor tumor-immune cell interactions via the blood could be of great value."

"Toner anticipates that the Cluster-Chip will play an important role in stimulating new research on CTC cluster biology:"

and to develop even better technologies to understand their biology in cancer metastasis


www.nanotech-now.com 2015 00557.txt.txt

#Computing at the speed of light: Utah engineers take big step toward much faster computers The Utah engineers have developed an ultracompact beamsplitter--the smallest on record--for dividing light waves into two separate channels of information.


www.nanotech-now.com 2015 00565.txt.txt

New device offers clues Why do some cancer cells break away from a tumor and travel to distant parts of the body?

2015 Cancer becomes deadly when it spreads, or metastasizes. Not all cells have the same ability to travel through the body,

The differences in individual cancer cells are a key aspect of how cancer evolves becomes resistant to current therapies or recurs."

"A primary tumor is not what kills patients. Metastases are what kill patients. Understanding which cells are likely to metastasize can help us direct more targeted therapies to patients,

"says co-senior study author Sofia D. Merajver, M d.,Ph d.,scientific director of the breast oncology program at the University of Michigan Comprehensive Cancer Center.

The researchers believe this type of device might some day help doctors understand an individual patient's cancer.

Which cells in this patient's tumor are really causing havoc? Is there a large population of aggressive cells?

"In this work, extensive studies were performed on cell lines representing various types of cancer. The new device was designed to trace how cells move, sorting individual cells by their movement.

and appearance under the microscope of metastatic cells and expressed significantly higher levels of markers associated with metastatic cancer."

"Understanding specific differences that lead some cancer cells to leave the primary tumor and seed metastases is of great benefit to develop

Patients seeking more information about their options for cancer treatment can call the U-M Cancer Answerline at 800-865-1125 5


www.nanotech-now.com 2015 00578.txt.txt

2015effective Nano-Micelles Designed in Iran to Treat Cancer May 20th, 2015announcements SUNY Poly CNSE and NIOSH Launch Federal Nano Health and Safety Consortium:

2015effective Nano-Micelles Designed in Iran to Treat Cancer May 20th, 2015environment Nano-policing pollution May 13th, 2015chemists strike nano-gold:


www.nanotech-now.com 2015 00582.txt.txt

drug testing, stem cell therapies and the delivery of drugs directly to the site of infection.

2015nanomedicine Effective Nano-Micelles Designed in Iran to Treat Cancer May 20th, 2015nature inspires first artificial molecular pump:

Simple design mimics pumping mechanism of life-sustaining proteins found in living cells May 19th, 2015studying dynamics of ion channels May 18th, 2015organic nanoparticles, more lethal to tumors:

Carbon-based nanoparticles could be used to sensitize cancerous tumors to proton radiotherapy and induce more focused destruction of cancer cells, a new study shows May 18th,

2015effective Nano-Micelles Designed in Iran to Treat Cancer May 20th, 2015materials/Metamaterials Taking control of light emission:

, more lethal to tumors: Carbon-based nanoparticles could be used to sensitize cancerous tumors to proton radiotherapy

and induce more focused destruction of cancer cells, a new study shows May 18th, 2015wearables may get boost from boron-infused graphene:

May 6th, 2015improving Clinical Care and Patient Quality of life in Advanced Liver disease, d-LIVER Workshop, Milan, 27 may 2015 May 6th, 201 0


www.nanotech-now.com 2015 00606.txt.txt

#Nanotechnology identifies brain tumor types through MRI'virtual biopsy'in animal studies: If results are confirmed in humans,

tumor cells could someday be diagnosed by MRI imaging and treated with tumor-specific IV injections;

new NIH grant will fund future study Abstract: Biomedical researchers at Cedars-Sinai have invented a tiny drug-delivery system that can identify cancer cell types in the brain through"virtual biopsies

"and then attack the molecular structure of the disease. If laboratory research with mice is borne out in human studies,

and fight tumor cells in the brain without resorting to surgery.""Our nanodrug can be engineered to carry a variety of drugs,

proteins and genetic materials to attack tumors on several fronts from within the brain,"said Julia Ljubimova, MD, Phd,

Ljubimova, director of the Nanomedicine Research center in the Department of Neurosurgery and director of the Nanomedicine Program at the Samuel Oschin Comprehensive Cancer Institute, has received a $2. 5 million grant from the National institutes of health to continue the research.

or stop cancers by blocking them in multiple ways within the brain. The drug is about 20 to 30 nanometers in size-a fraction of a human hair,

such as seeking out cancer cells and binding to them, permeating the walls of blood vessels and tumor cells,

or dismantling molecular mechanisms that promote tumor growth, "said Eggehard Holler, Phd, professor of neurosurgery and director of nanodrug synthesis at Cedars-Sinai.

diagnosing brain tumors by identifying cells that have spread to the brain from other organs, and then fighting the cancer with precise, individualized tumor treatment.

Researchers can determine tumor type by attaching a tracer visible on an MRI. If the tracer accumulates in the tumor,

it will be visible on MRI. With the cancer's molecular makeup identified through this virtual biopsy,

researches can load the"delivery system"with cancer-targeting components that specifically attack the molecular structure.

To show that the virtual biopsies could distinguish one cancer cell type from another, the researchers devised what is believed to be a unique method,

implanting different kinds of breast and lung cancers into laboratory mice to represent metastatic disease-with one type of cancer implanted on each side of the brain.

Lung and breast cancers are those that most often spread to the brain. The researchers used the nano delivery system to identify

and attack the cancers. In each instance, animals that received treatment lived significantly longer than those in control groups."

"Several drugs are quite effective in treating different types of breast cancers, lung cancer, lymphoma and other cancers at their original sites,

but they are ineffective against cancers that spread to the brain because they are not able to cross the blood-brain barrier that protects the brain from toxins in the blood,

Brain tumor Center and the Ruth and Lawrence Harvey Chair in Neuroscience.""The nanodrug is engineered to cross this barrier with its payload intact,

and the Samuel Oschin Comprehensive Cancer Institute contributed to the study with colleagues from the University of Southern California and Arrogene Inc,

The new NIH National Cancer Institute grant R01ca188743, will fund ongoing study.#####For more information, please click herecontacts:

May 27th, 2015fine-tuned molecular orientation is key to more efficient solar cells May 26th, 2015cancer Iranian Scientists Use Magnetic field to Transfer Anticancer Drug to Tumor Tissue May 24th,

The photonics advancement could improve early cancer detection, nanoelectronics manufacturing and scientists'ability to observe single molecules May 23rd,

The photonics advancement could improve early cancer detection, nanoelectronics manufacturing and scientists'ability to observe single molecules May 23rd, 2015aspen Aerogels to Present at the Cowen and Company Technology,

Scientists Use Magnetic field to Transfer Anticancer Drug to Tumor Tissue May 24th, 2015discoveries Who needs water to assemble DNA?

The photonics advancement could improve early cancer detection, nanoelectronics manufacturing and scientists'ability to observe single molecules May 23rd,201 0


www.nanotech-now.com 2015 00633.txt.txt

foam-like battery material that can withstand shock and stress.""It is possible to make incredible materials from trees


www.nanotech-now.com 2015 00646.txt.txt

135 K) which caused the"high-Tc fever"in the world 30 years ago, it obviously exceeds the record of other"high-Tc superconductors"such as fullerene (C60) superconductors (Tc 33 K) and Mgb2 (Tc 39k),


www.nanotech-now.com 2015 00683.txt.txt

"finding a nanothermometer sensitive enough at this scale is a great step forward in the field of nanotechnology, with applications in biology, chemistry, physics and even in the diagnosis and treatment of diseases


www.nanotech-now.com 2015 00697.txt.txt

2015new sensing tech could help detect diseases, fraudulent art, chemical weapons June 1st, 2015thin coating on condensers could make power plants more efficient:


www.nanotech-now.com 2015 00712.txt.txt

News and information A step towards a type 1 diabetes vaccine by using nanotherapy June 10th, 2015investigation of Optical Properties of Quantum dots in Presence of Magnetic, Electrical Fields June 10th,

2015discoveries A step towards a type 1 diabetes vaccine by using nanotherapy June 10th, 2015investigation of Optical Properties of Quantum dots in Presence of Magnetic, Electrical Fields June 10th,

2015announcements A step towards a type 1 diabetes vaccine by using nanotherapy June 10th, 2015investigation of Optical Properties of Quantum dots in Presence of Magnetic, Electrical Fields June 10th,

2015interviews/Book reviews/Essays/Reports/Podcasts/Journals/White papers A step towards a type 1 diabetes vaccine by using nanotherapy June 10th,


www.nanotech-now.com 2015 00746.txt.txt

but buckled due to changes of the internal stress in the layer during the etching process.


www.nanotech-now.com 2015 00763.txt.txt

"The team tested the therapeutic potential of the nanoparticles by loading them with an anti-melanoma drug

In further experiments, the researchers found they could alter the infusion of the particles into melanoma cells by adjusting the polymer coatings.

"This is a versatile platform to carry a multitude of drugs-for melanoma, for other kinds of cancers and for other diseases,


www.nanotech-now.com 2015 00792.txt.txt

Remote-controlled Eradication of Astrogliosis in Spinal cord Injury via Electromagnetically-induced Dexamethasone Release from"Smart"Nanowireswen Gao and Richard Borgenswe describe a system to deliver drugs to selected tissues continuously,

and deposited onto a spinal cord lesion in Glial fibrillary acidic protein-luc Transgenic mices (GFAP-luc mice). Overexpression of GFAP is an indicator of astrogliosis/neuroinflammation in CNS injury.

The corticosteroid DEX, a powerful ameliorator of inflammation, was released from the polymer by external application of an Electromagnetic field for 2 hours/day for a week.

and wires required by other implantable devices that can lead to infection and other complications, said team leader Richard Borgens, Purdue University's Mari Hulman George Professor of Applied Neuroscience and director of Purdue's Center for Paralysis Research."

"This tool allows us to apply drugs as needed directly to the site of injury, which could have broad medical applications,

"Borgens said.""The technology is in the early stages of testing, but it is our hope that this could one day be used to deliver drugs directly to spinal cord injuries, ulcerations, deep bone injuries or tumors,

and avoid the terrible side effects of systemic treatment with steroids or chemotherapy.""The team tested the drug-delivery system in mice with compression injuries to their spinal cords

and administered the corticosteroid dexamethasone. The study measured a molecular marker of inflammation and scar formation in the central nervous system and found that it was reduced after one week of treatment.

Wen Gao, a postdoctoral researcher in the Center for Paralysis Research who worked on the project with Borgens

and transported a patch of the nanowire carpet on water droplets that were used used to deliver it to the site of injury.

The nanowire patches adhere to the site of injury through surface tension Gao said. The magnitude and wave form of the electromagnetic field must be tuned to obtain the optimum release of the drug,

Youngnam Cho, a former faculty member at Purdue's Center for Paralysis Research; and Jianming Li, a research assistant professor at the center.

GFAP is expressed in cells called astrocytes that gather in high numbers at central nervous system injuries. Astrocytes are a part of the inflammatory process and form a scar tissue,

A 1-2 millimeter patch of the nanowires doped with dexamethasone was placed onto spinal cord lesions that had been exposed surgically,

The lesions were closed then and an electromagnetic field was applied for two hours a day for one week.

###The research was funded through the general funds of the Center for Paralysis Research and an endowment from Mrs. Mari Hulman George. Borgens has a dual appointment in Purdue's College of Engineering and the College of Veterinary medicine.##

Cancer Nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis June 23rd, 2015news and information Nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis June 23rd, 2015sweeping lasers snap together nanoscale geometric grids:

New technique creates multilayered, self-assembled grids with fully customizable shapes and compositions June 23rd,

2015nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis June 23rd, 2015newly-Developed Biosensor in Iran Detects Cocaine addiction June 23rd,

2015discoveries Nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis June 23rd, 2015sweeping lasers snap together nanoscale geometric grids:

2015announcements Nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis June 23rd, 2015sweeping lasers snap together nanoscale geometric grids:

2015nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis June 23rd, 2015iranian Scientists Design Nano Device to Detect Cyanogen Toxic Gas June 23rd,201 0


www.nanotech-now.com 2015 00795.txt.txt

4-D printing to advance chemistry, materials sciences and defense capabilities June 18th, 2015discoveries Nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis June 23rd, 2015sweeping lasers snap together


www.nanotech-now.com 2015 00797.txt.txt

News and information Scientists highlight the importance of nanoscale hybrid materials for noninvasive cancer diagnosis June 24th,

and the Environment June 24th, 2015discoveries Scientists highlight the importance of nanoscale hybrid materials for noninvasive cancer diagnosis June 24th,

2015announcements Scientists highlight the importance of nanoscale hybrid materials for noninvasive cancer diagnosis June 24th, 2015physicists fine-tune control of agile exotic materials:

and the Environment June 24th, 2015interviews/Book reviews/Essays/Reports/Podcasts/Journals/White papers Scientists highlight the importance of nanoscale hybrid materials for noninvasive cancer diagnosis June 24th,


www.nanotech-now.com 2015 00830.txt.txt

News and information June 29th, 2015efforts to Use Smart Nanocarriers to Cure Leukemia Yield Promising Results June 29th, 2015making new materials with micro-explosions:

A novel microscope for nanosystems June 25th, 2015iranian Researchers Synthesize Nanostructures with Controlled Shape, Structure June 25th, 2015discoveries June 29th, 2015efforts to Use Smart Nanocarriers to Cure Leukemia Yield

New technique combines electron microscopy and synchrotron X-rays to track chemical reactions under real operating conditions June 29th, 2015announcements June 29th, 2015efforts to Use Smart Nanocarriers to Cure Leukemia Yield Promising


www.nanotech-now.com 2015 00845.txt.txt

its high concentration causes digestive malfunctions and results in the related diseases due to its toxicity.

chemotherapy packed nanoparticles may target cancer stem cells June 30th, 2015graphene flexes its electronic muscles: Rice-led researchers calculate electrical properties of carbon cones, other shapes June 30th,

2015researchers from the UCA, key players in a pioneering study that may explain the origin of several digestive diseases June 30th,

2015researchers from the UCA, key players in a pioneering study that may explain the origin of several digestive diseases June 30th,

2015researchers from the UCA, key players in a pioneering study that may explain the origin of several digestive diseases June 30th,


www.nanotech-now.com 2015 00848.txt.txt

and innovation programm 1 e. Its main objective is to reach a level of international excellence in nanomedicine characterisation for medical indications like cancer, diabetes, inflammatory diseases or infections,

EU-NCL is partnered with the sole international reference facility, the Nanotechnology Characterization Lab of the National Cancer Institute in the U s. US-NCL) 3,

This venture holds great promise for using nanotechnologies to overcome cancer and other major diseases around the world.


www.nanotech-now.com 2015 00869.txt.txt

#New Biosensor Produced in Iran to Detect Effective Drugs in Cancer Treatment Iranian researchers designed a biosensor with application in assessment of effectiveness of drugs on the stability of the four-strand structure of DNA to prevent the growth

The four-strand structure of DNA plays an important role in the process of creation of cancerous cells and in the prohibition of a type of active enzyme in cancers.


www.nanotech-now.com 2015 00878.txt.txt

or viral infection in less time than it would take conventional tests and it would cost less as well.

and combat highly infectious diseases, including Hepatitis C, SARS or MERS, could also benefit from the user friendly chip

and its rapid results. is award is truly helping our lab become translational, said UCSB mechanical engineering professor Sumita Pennathur. t a big step forward in terms of bringing out nanofluidic technology to real biomedical applications of disease diagnosis

. I'm so excited for him!


www.nanotech-now.com 2015 00880.txt.txt

#Crystal structure and magnetism--new insight into the fundamentals of solid state physics: HZB team decodes relationship between magnetic interactions and the distortions in crystal structure within a geometrically'frustrated'spinel system Abstract:

A team at HZB has carried out the first detailed study of how magnetic and geometric ordering mutually influence one another in crystalline samples of spinel.


www.nanotech-now.com 2015 00881.txt.txt

and record the complex 3-D magnetization in wound magnetic layers. This technique could be important in the development of devices that are highly sensitive to magnetic fields,


www.nanotech-now.com 2015 00886.txt.txt

#Sensor technology can improve accuracy of prostate cancer diagnosis, research shows Abstract: New research has shown how a smart sensor chip,

and efficiency of prostate cancer diagnosis. Researchers at the University of Birmingham believe that the novel technology will help improve the process of early stage diagnosis. Glycoprotein molecules,

Because of their essential role in our immune response, they are useful clinical biomarkers for detecting prostate cancer and other diseases.

In doing so, they developed a more accurate and efficient way of diagnosing prostate cancer than the current tests

the team wanted to identify the presence of disease by detecting a particular glycoprotein which has specific sugars in a specific location in the molecule.

the sugar part of the prostate cancer glycoprotein is reacted with a custom-designed molecule that contains a boron group at one end (the boron linkage forms a reversible bond to the sugar).

and the only key that will fit is the specific prostate cancer glycoprotein that we're looking for.

"Dr John Fossey added,"It's estimated that one in eight men will suffer from prostate cancer at some point in their life,

and collaboration with commercial partners, will open the door to adapting the current technology for other diseases.

Lots of diseases produce specific glycoproteins, so there are a number of possible avenues to improve the accuracy of our diagnoses


www.nanotech-now.com 2015 00892.txt.txt

which could overcome current shortcomings of low drug efficacy and multi-drug resistance in the treatment of cancer as well as viral and bacterial infections.

the study identified a new mechanism of targeting multi-subunit complexes that are critical to the function of viruses, bacteria or cancer,

Guo holds a joint appointment at the UK Markey Cancer Center and in the UK College of Pharmacy."

or die and thus, no longer able to cause disease.""One of the vexing problems in the development of drugs is drug resistance,

"Dr. Guo's study has identified a new mechanism of efficiently inhibiting biological processes that are critical to the function of the disease-causing organism,

"##Guo focuses much of his work on the use of ribonucleic acid (RNA) nanoparticles and a viral nanomotor to fight cancer, viral infections and genetic diseases.


www.nanotech-now.com 2015 00894.txt.txt

TVOC is known as a carcinogen that can cause disability in the nervous system from skin contact or from inhalation through respiratory organs s


www.nanotech-now.com 2015 00913.txt.txt

News and information SUNY Poly CNSE to Present Cutting-edge Semiconductor Technology Developments at SEMICON West 2015 Conference July 10th, 2015super graphene can help treat cancer July 10th,

2015super graphene can help treat cancer July 10th, 2015graphene-based film can be used for efficient cooling of electronics July 10th,

2015new Biosensor Produced in Iran to Detect Effective Drugs in Cancer Treatment July 4th, 2015discoveries Super graphene can help treat cancer July 10th,

2015graphene-based film can be used for efficient cooling of electronics July 10th, 2015scientists Apply Magnetic nanoparticles to Eliminate Cancerous Cells July 10th,

Replacing silver coating on catheters with graphene increases treatment effect July 9th, 2015materials/Metamaterials Super graphene can help treat cancer July 10th,

2015super graphene can help treat cancer July 10th, 2015graphene-based film can be used for efficient cooling of electronics July 10th,

2015interviews/Book reviews/Essays/Reports/Podcasts/Journals/White papers Super graphene can help treat cancer July 10th, 2015graphene-based film can be used for efficient cooling of electronics July 10th,


www.nanotech-now.com 2015 00919.txt.txt

Pseudomonas aeruginosa, a common disease-causing bacterium; Ralstonia, a genus of bacteria containing numerous soil-borne pathogen species;

and Staphylococcus epidermis, a bacterium that can cause harmful biofilms on plastics-like catheters-in the human body.


www.nanotech-now.com 2015 00928.txt.txt

#Nanospheres shield chemo drugs, safely release high doses in response to tumor secretions Scientists have designed nanoparticles that release drugs in the presence of a class of proteins that enable cancers to metastasize.

so that the very enzymes that make cancers dangerous could instead guide their destruction.""We can start with a small molecule

and build that into a nanoscale carrier that can seek out a tumor and deliver a payload of drug,

The system takes advantage of a class enzymes called matrix metalloproteinases that many cancers make in abundance.

The shell fragments form a ragged mesh that holds the drug molecules near the tumor.

builds on his group's earlier sucess using a similar strategy to mark tumors for both diagnosis and precise surgical removal.

That means the drug was inactivated as it flowed through the circulatory system until it reached the tumor.

The protection allowed the researchers to safely give a dose 16 times higher than they could with the formulation now used in cancer clinics,

in a test in mice with grafted in fibrosarcoma tumors. In additional preliminary tests, Callmann and colleagues were able to halt the growth of the tumors for a least two weeks,

using a single lower dose of the drug. In mice treated with the nanoparticles coated with peptides that are impervious to MMPS or given saline,

the tumors grew to lethal sizes within that time. Gianneschi says they will broaden their approach to create delivery systems for other diagnostic and therapeutic molecules."

We'll test this in other models-with other classes of drug and in mice with a cancer that mimics metastatic breast cancer, for example."

"##Additional authors include Matthew Thompson in Gianneschi's chemistry research group and Christopher Barback, David Hall and Robert Mattrey in UC San diego's Moores Cancer Center.

Callmann holds a fellowship through the Cancer Researchers in Nanotechnology Program at UC San diego. The National Institute of Biomedical Imaging


www.nanotech-now.com 2015 00930.txt.txt

This can allow scientists to see fine features of objects such as tumors, or minute flaws within airplane wings in industrial testing, that may otherwise be unobservable due to an instrument's diffractive limit.


www.nanotech-now.com 2015 00940.txt.txt

and training the body's own immune system to better fight cancer and infection. Now, results of a study led by Johns Hopkins investigators suggests that a device composed of a magnetic column paired with custom-made magnetic nanoparticles may hold a key to bringing immunotherapy into widespread and successful clinical use.

and rapidly multiplying immune system white blood cells known as T cells because of their potential as an effective weapon against cancer,

according to Jonathan Schneck, M d.,Ph d.,a professor of pathology, medicine and oncology at the Johns hopkins university School of medicine's Institute for Cell Engineering."

that we could use them as the basis of a therapy for cancer patients. We've taken a big step toward solving that problem,

This process activates the T cells to ward off a virus, bacteria or tumor, as well as to make more T cells.

priming the T cells both to battle the target cancer and divide to form more activated cells.

humans with magnetic aapcs bearing antigens from tumors. They then ran the plasma through a magnetic column.

The tumor-fighting T cells bound to aapcs and stuck to the sides of the column,

which relies on other white blood cells called tumor-infiltrating lymphocytes. Those cells are trained already"to fight cancer,

and researchers have shown some success isolating some of the cells from tumors, inducing them to divide,

and then transferring them back into patients. But, Schneck says, not all patients are eligible for this therapy,

because not all have tumor-infiltrating lymphocytes. By contrast, all people have naive T cells, so patients with cancer could potentially benefit from the new approach

whether or not they have tumor-infiltrating lymphocytes.""The aapcs and magnetic column together provide the foundation for simplifying

and streamlining the process of generating tumor-specific T cells for use in immunotherapy, "says Juan carlos Varela, M d.,Ph d,

. a former member of Schneck's laboratory who is now an assistant professor at the Medical University of South carolina.

which they say could help combat the problem of tumors mutating to evade the body's defenses."

While the team initially tested the new method only on cancer antigens, Schneck says it could also potentially work for therapies against chronic infectious diseases, such as HIV.

He says that if further testing goes well, clinical trials of the technique could begin within a year and a half.##

This work was supported by the National Institute of Allergy and Infectious diseases (grant numbers AI072677 and AI44129),

the National Institute of General Medical sciences (grant number GM 07309), the National Cancer Institute (grant numbers CA 43460, CA 62924, CA 09243 and CA108835), the Troper Wojcicki

Foundation, the Virginia and D. K. Ludwig Fund for Cancer Research, the Sol Goldman Center for Pancreatic cancer Research,

safely release high doses in response to tumor secretions July 14th, 2015chemotherapeutic coatings enhance tumor-frying nanoparticles:

Duke university researchers add a drug delivery mechanism to a nanoparticle therapy already proven to target,

heat and destroy tumors July 13th, 2015super graphene can help treat cancer July 10th, 2015govt. -Legislation/Regulation/Funding/Policy Researchers Build a Transistor from a Molecule and A few Atoms July 14th, 2015world first:

Significant development in the understanding of macroscopic quantum behavior: Researchers from Polytechnique Montral and Imperial College London demonstrate the wavelike quantum behavior of a polariton condensate on a macroscopic scale and at room temperature July 14th, 2015nanospheres shield chemo drugs,

safely release high doses in response to tumor secretions July 14th, 2015better memory with faster lasers July 14th,

safely release high doses in response to tumor secretions July 14th, 2015chemotherapeutic coatings enhance tumor-frying nanoparticles:

Duke university researchers add a drug delivery mechanism to a nanoparticle therapy already proven to target,

heat and destroy tumors July 13th, 2015magnetic hyperthermia, an auxiliary tool in cancer treatments July 8th, 2015discoveries For faster,

safely release high doses in response to tumor secretions July 14th, 2015globalfoundries Completes Acquisition of IBM Microelectronics Business:


< Back - Next >


Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011